A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical On
about
A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical On
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A randomized Phase III trial o ...... lung cancer: Japan Clinical On
@en
A randomized Phase III trial o ...... stereotactic body radiotherapy
@nl
type
label
A randomized Phase III trial o ...... lung cancer: Japan Clinical On
@en
A randomized Phase III trial o ...... stereotactic body radiotherapy
@nl
prefLabel
A randomized Phase III trial o ...... lung cancer: Japan Clinical On
@en
A randomized Phase III trial o ...... stereotactic body radiotherapy
@nl
P2093
P2860
P356
P1476
A randomized Phase III trial o ...... lung cancer: Japan Clinical On
@en
P2093
Masahiro Hiraoka
Radiation Oncology Study Group of the Japan Clinical Oncology Group
Satoshi Ishikura
Taro Shibata
Tomoki Kimura
Yasumasa Nishimura
Yasushi Nagata
Yoshinori Ito
P2860
P304
P356
10.1093/JJCO/HYW198
P577
2017-01-09T00:00:00Z